Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1050378

registered interest
date	29/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of trends in the level of availability of the 2018-19 seasonal flu vaccine.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	214044
answer	answer is ministerial correction date of answer 06/02/2019 answer text <p>Public Health England (PHE) provides influenza vaccines centrally for the children’s influenza programme. Centrally purchased influenza vaccines are carefully monitored by PHE to ensure there is equitable distribution across England and sufficient in-date vaccine for patients who present throughout the season.</p><p> </p><p>General practitioners and other providers are directly responsible for the influenza vaccine supplies used to deliver the national influenza programme to the other eligible groups. PHE maintains oversight to help facilitate a constant supply of vaccine, liaising with vaccine manufacturers to ascertain whether there are any manufacturing problems which could impact the running of the programme at a national level.</p><p> </p><p>This winter, eligible adults aged 18-64 were offered a quadrivalent influenza vaccine, and those aged 65 and over were offered a newly licensed adjuvanted trivalent influenza vaccine (aTIV). There were a number of short-term localised shortages of both vaccines reported, particularly for aTIV due to staggered deliveries from the manufacturer between September and November. The NHS managed these shortages locally, but some patients had to wait longer than usual to be vaccinated. However, there was no overall shortage of either vaccine.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/02/2019 14:59:51 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

1052234

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Allergies: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 10 December 2018 to Question 198805, what progress has been made on increasing the supply of Epipens; and if he will make a statement.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	215243
answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>Supplies of EpiPen and other adrenaline auto-injectors are currently available in volumes that are sufficient to meet United Kingdom requirements. The Department continues to work very closely with all the manufacturers of adrenaline auto-injectors and can confirm that the supply situation continues to improve going forward with further deliveries expected over the coming weeks. All patients who require an adrenaline auto-injector should now be able to obtain a device from their pharmacy.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2019 12:28:31 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

1052240

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bacteriophages
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential benefits of phage therapy for tackling antimicrobial resistance.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	215244
answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>The Department and the Wellcome Trust sponsored a strategic pipeline briefing into alternatives to antibiotics in 2015. The briefing reviewed the feasibility and potential clinical impact of alternatives to antibiotics, including bacteriophages, and considered approaches that were most likely to deliver new treatments in the next 10 years. The briefing concluded that bacteriophages were possible therapeutics, but too few were being progressed.</p><p> </p><p>The Government continues to invest in research into new and alternative treatments. While there has been increased investment and unprecedented levels of research collaboration on antimicrobial resistance, there are still relatively few projects looking at the use of bacteriophages.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2019 12:26:34 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

1052242

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has plans to increase the level of investment and funding for training and employing NHS microbiologists on long term contracts to increase diagnostic capacity as part of the government strategy to tackle antimicrobial resistance.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	215245
answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>‘Tackling Antimicrobial Resistance (2019-2024): the UK’s five-year national action plan’ includes the commitment to assess current and future workforce needs to ensure capability and capacity for strong infection prevention and control and antimicrobial stewardship. The assessment will cover a range of roles, including microbiology. The results of the assessment will be used to develop further workforce targets.</p><p> </p><p>The NHS England Long Term Plan makes the commitment to implement the human health aspects of the national action plan.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2019 12:29:36 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

1052243

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to establish an evidential basis on the time taken to diagnose disease in the NHS as part of the Antimicrobial Resistance Strategy.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	215246
answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>‘Tackling Antimicrobial Resistance (2019-2024): the UK’s five-year national action plan’ recognises that stewardship programmes are needed for both therapeutics and diagnostics. Good diagnostic stewardship promotes appropriate and timely testing.</p><p> </p><p>Evidence suggests that a third of prescriptions in primary care do not have an associated diagnosis recorded. The national action plan sets out an ambition to improve the evidence base about diagnoses and prescriptions by linking and analysing clinical data sets.</p><p> </p><p>Through the joint sepsis/Antimicrobial Resistance Commissioning for Quality Innovation data we know that the number of patients being identified with a suspicion of sepsis or severe infection has increased and that a majority of those patients have their treatment reviewed within 24-72 hours, following the confirmation of diagnostic test results.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2019 12:40:27 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

1052244

registered interest
date	31/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Antimicrobials: Drug Resistance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Government's strategy entitled Tackling antimicrobial resistance 2019–2024: The UK’s five-year national action plan, published in January 2019, what plans his Department has to educate the public on the use and misuse of antimicrobials and their role in tackling antimicrobial resistance.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	215247
answer	answer is ministerial correction date of answer 08/02/2019 answer text <p>Public Health England has developed a number of initiatives for educating the public which support the Government’s recently published strategy to tackle antimicrobial resistance; including a major national campaign, ‘Keep Antibiotics Working’, following a successful pilot in the North West in October 2017, to alert the general public to the issue of antibiotic resistance, with the aim of reducing patient pressure on general practitioners to prescribe. The multi-media campaign, which features advertising on television, radio, outdoor, digital, social media, public relations and extensive partnership support, has run for a consecutive year in 2018. Further information is available at the following link:</p><p> </p><p><a href="https://antibioticguardian.com/keep-antibiotics-working/" target="_blank">https://antibioticguardian.com/keep-antibiotics-working/</a></p><p> </p><p>The United Kingdom wide Antibiotic Guardian campaign, now in its fifth year, aims to stimulate behaviour change and increase engagement to tackle antimicrobial resistance by healthcare professionals and engaged members of the public. The e-Bug programme, now celebrating its 10th year, aims to educate children, young people and communities about microbes, hygiene, infections and antibiotics. Further information on the e-Bug programme is available at the following link:</p><p> </p><p><a href="http://www.e-Bug.eu" target="_blank">www.e-Bug.eu</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2019 12:27:48 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

1064303

registered interest
date	20/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Professions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the Health Education England phase two cancer workforce plan co-ordinates with the workforce implementation plan in the NHS Long Term Plan.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	223778
answer	answer is ministerial correction date of answer 26/02/2019 answer text <p>Health Education England (HEE) published its first ever Cancer Workforce Plan in December 2017. HEE intended to publish a second phase, longer-term strategy that looked at the cancer workforce needs beyond 2021. This work was started and stakeholders from within the National Health Service and the charitable sector contributed to the early discussions. This work has since been superseded by publication of the NHS Long Term Plan in January 2019.</p><p> </p><p>My Rt. hon. Friend Secretary of State for Health and Social Care has subsequently commissioned Baroness Dido Harding, working closely with Sir David Behan, to lead a number of programmes to engage with key NHS interests to develop a detailed workforce implementation plan. These programmes will consider detailed proposals to grow the workforce rapidly, including staff working on cancer, consider additional staff and skills required, build a supportive working culture in the NHS and ensure first rate leadership for NHS staff.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 26/02/2019 12:17:17 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire

1087041

registered interest
date	12/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the effectiveness of the PACE trial of therapies on reducing the effects of (a) myalgic encephalomyelitis and (b) chronic fatigue syndrome.
tabling member constituency	Bristol West
tabling member printed	Thangam Debbonaire
uin	231512
answer	answer is ministerial correction date of answer 20/03/2019 answer text <p>The PACE trial, undertaken by Queen Mary University of London, was the largest ever trial of therapies for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). The trial aimed to test and compare the effectiveness of four of the main treatments available for people CFS/ME. These were adaptive pacing therapy, cognitive behaviour therapy (CBT), graded exercise therapy, and standardised specialist medical care (SMC).</p><p> </p><p>The five-year trial involved over 600 participants, aged 18 and over, in Scotland and England. The first set of results from the trial were published in 2011 in the Lancet, and a number of other evaluations based on the trial have been published since. The trial results found both CBT and GET were moderately effective when provided alongside SMC and were better than adaptive pacing therapy or SMC alone in improving both symptoms and disability.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) guideline ‘Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): Diagnosis and management of CFS/ME in adults and children’, sets outs best practice for clinicians on the diagnosis, treatment, care and support of people with the condition. The guideline recommends CBT and GET as appropriate treatments for mild to moderate CFS/ME, in line with the best available evidence.</p><p> </p><p>The NICE guideline acknowledges that there is no one form of treatment to suit every patient and that treatment and care should take into account the personal needs and preferences of the patient. Decisions concerning the appropriateness of treatments should be made on a case by case basis.</p><p> </p><p>On 20 September 2017, NICE announced its decision to undertake a full update of the guideline, following a review of the latest available evidence on the diagnosis and management of CFS/ME and a public consultation. New guidance is expected in October 2020. More information on this decision can be found at the following link:</p><p> </p><p><a href="http://www.nice.org.uk/news/article/nice-to-begin-review-of-its-guidance-on-the-diagnosis-and-treatment-of-cfs-me" target="_blank">www.nice.org.uk/news/article/nice-to-begin-review-of-its-guidance-on-the-diagnosis-and-treatment-of-cfs-me</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/03/2019 16:33:27 answering member 4067 label Biography information for Steve Brine
tabling member	4433 label Biography information for Thangam Debbonaire